Antihypertensive Agents
Cancer Pain
Clonidine
Tics
Tourette Syndrome

Clonidine

Clonidine is a central alpha-2 adrenergic and imidazoline receptor agonist that lowers blood pressure and heart rate by decreasing sympathetic outflow, leading to vasodilation and improved myocardial perfusion. Clonidine holds Food and Drug Administration approved indications beyond antihypertensive therapy, including treatment of attention-deficit/hyperactivity disorder in children, management of tics associated with Tourette syndrome, and adjunctive therapy for severe cancer-related pain. This activity reviews the mechanism of action, indications, adverse event profile, toxicity, dosing, drug interactions, and monitoring of clonidine, providing a comprehensive understanding of its pharmacology. Mastery of these aspects enables healthcare professionals to individualize treatment plans, optimize therapeutic outcomes, and minimize adverse events, ensuring safe and effective use of clonidine in diverse patient populations. Participants in this activity gain knowledge that enhances their ability to evaluate, prescribe, and monitor clonidine therapy effectively. The course emphasizes the importance of collaboration within the interprofessional healthcare team, demonstrating how shared expertise among clinicians and pharmacists improves patient care. By understanding each team member’s role in monitoring response, adjusting dosing, and managing potential adverse effects, participants learn to optimize treatment outcomes and ensure patient safety. The program enhances competence in both pharmacological decision-making and team-based care, demonstrating how interprofessional collaboration fosters patient-centered approaches and ultimately leads to improved clinical outcomes for patients receiving clonidine therapy.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.